- Home
- ZTO vs CANF Comparison
ZTO vs CANF Comparison
Compare ZTO & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZTO | CANF |
|---|---|---|
| Founded | 2002 | 1994 |
| Country | China | Israel |
| Employees | 23913 | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3B | 4.7M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | ZTO | CANF |
|---|---|---|
| Price | $24.99 | $3.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $21.90 | ★ $9,750.00 |
| AVG Volume (30 Days) | ★ 1.7M | 38.3K |
| Earning Date | 05-19-2026 | 03-26-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.97 | $2,715,455.50 |
| Revenue Next Year | $9.60 | $101.06 |
| P/E Ratio | $21.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.34 | $0.17 |
| 52 Week High | $26.20 | $10.40 |
Technical Indicators
Market Signals| Indicator | ZTO | CANF |
|---|---|---|
| Relative Strength Index (RSI) | 56.71 | 40.33 |
| Support Level | $17.94 | $0.59 |
| Resistance Level | $25.86 | $4.74 |
| Average True Range (ATR) | 0.72 | 0.18 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 59.39 | 34.33 |
Price Performance
Historical ComparisonAbout ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 19.4% in 2024. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 78% voting rights as of March 31, 2025. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 8.9% interest.
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.